About
Colin Hill co-founded GNS Healthcare in 2000 and has served as Chairman & CEO since then. He brings impressive leadership experience and a solid track record in commercializing machine learning technology and precision medicine platforms in the biopharmaceutical and managed care industries. In 2016, he was appointed to the board of directors of a leading publically traded mobile health company that pioneered remote cardiac monitoring – Biotelemetry Inc. (formerly CardioNet) (NASDAQ: BEAT). He was appointed in 2015 by Massachusetts Governor Charlie Baker to the board of directors of the Center for Health Information and Analysis. He is also a founding board member of Transforming Medicine: The Elizabeth Kauffman Institute, a non-profit foundation (501c3) dedicated to the advancement of personalized medicine. He was a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease (acquired by Baxter i
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Colin Hill is one of them.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Cambridge, US
Contact Information
Find more investors like Colin
Search Investors